Scinovex
article Open Access

Study of serum interleukin 35 level in patients with acute myeloid leukemia

Fagr Ahmed El ZahabySarah M. ShoeibAmro Ahmed TahaSahar Mohey Eldin Hazzaa

Abstract

Background: Acute myeloid leukaemia (AML) is a dangerous cancer of the blood-forming stem cells, which leads to a rise in the number of myeloid cells in the bone marrow. This may cause severe infections, bleeding, or the invasion of organs, ultimately leading in death. This research aimed to evaluate the significance of serum interleukin IL-35 levels in individuals with AML.Methods: Serum IL-35 was measured using enzyme-linked immunosorbent assays and evaluated as biomarkers for the diagnosis and prognosis.Results: There was positive significant correlation between serum IL-35 level and Age, WBC, peripheral blood blasts, BM blasts, lactate dehydrogenase (LDH), cluster of differentiation (CD) 45, myeloperoxidase (MPO), human leukocyte antigen - DR isotype (HLA-DR) and CD34 (p

Citations
2
FWCI
0.57
field-weighted impact
References
18
Percentile
68%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Study of serum interleukin 35 level in patients with acute myeloid leukemia · Scinovex